Skip to main content
Top
Published in: Respiratory Research 1/2007

Open Access 01-12-2007 | Research

Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model

Authors: Paola E Cogo, Gianna Maria Toffolo, Carlo Ori, Andrea Vianello, Marco Chierici, Antonina Gucciardi, Claudio Cobelli, Aldo Baritussio, Virgilio P Carnielli

Published in: Respiratory Research | Issue 1/2007

Login to get access

Abstract

Background

In patients with acute respiratory distress syndrome (ARDS), it is well known that only part of the lungs is aerated and surfactant function is impaired, but the extent of lung damage and changes in surfactant turnover remain unclear. The objective of the study was to evaluate surfactant disaturated-phosphatidylcholine turnover in patients with ARDS using stable isotopes.

Methods

We studied 12 patients with ARDS and 7 subjects with normal lungs. After the tracheal instillation of a trace dose of 13C-dipalmitoyl-phosphatidylcholine, we measured the 13C enrichment over time of palmitate residues of disaturated-phosphatidylcholine isolated from tracheal aspirates. Data were interpreted using a model with two compartments, alveoli and lung tissue, and kinetic parameters were derived assuming that, in controls, alveolar macrophages may degrade between 5 and 50% of disaturated-phosphatidylcholine, the rest being lost from tissue. In ARDS we assumed that 5–100% of disaturated-phosphatidylcholine is degraded in the alveolar space, due to release of hydrolytic enzymes. Some of the kinetic parameters were uniquely determined, while others were identified as lower and upper bounds.

Results

In ARDS, the alveolar pool of disaturated-phosphatidylcholine was significantly lower than in controls (0.16 ± 0.04 vs. 1.31 ± 0.40 mg/kg, p < 0.05). Fluxes between tissue and alveoli and de novo synthesis of disaturated-phosphatidylcholine were also significantly lower, while mean resident time in lung tissue was significantly higher in ARDS than in controls. Recycling was 16.2 ± 3.5 in ARDS and 31.9 ± 7.3 in controls (p = 0.08).

Conclusion

In ARDS the alveolar pool of surfactant is reduced and disaturated-phosphatidylcholine turnover is altered.
Literature
1.
go back to reference Ware LB, Matthay MA: The Acute Respiratory Distress Syndrome. New Engl J Med 2000, 342:1334–1349.CrossRefPubMed Ware LB, Matthay MA: The Acute Respiratory Distress Syndrome. New Engl J Med 2000, 342:1334–1349.CrossRefPubMed
2.
go back to reference Gattinoni L, Chiumello D, Cressoni M, Valenza F: Pulmonary computed tomography and adult respiratory distress syndrome. Swiss Med Wkly 2005, 135:169–174.PubMed Gattinoni L, Chiumello D, Cressoni M, Valenza F: Pulmonary computed tomography and adult respiratory distress syndrome. Swiss Med Wkly 2005, 135:169–174.PubMed
4.
go back to reference Frerking I, Gunther A, Seeger W, Pison U: Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med 2001, 27:1699–1717.CrossRefPubMed Frerking I, Gunther A, Seeger W, Pison U: Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med 2001, 27:1699–1717.CrossRefPubMed
5.
go back to reference Haitsma JJ, Papadakos PJ, Lachmann B: Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2004, 10:18–22.CrossRefPubMed Haitsma JJ, Papadakos PJ, Lachmann B: Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2004, 10:18–22.CrossRefPubMed
6.
go back to reference Panda AK, Nag K, Harbottle RR, Rodriguez-Capote K, Veldhuizen RA, Petersen NO, Possmayer F: Effect of acute lung injury on structure and function of pulmonary surfactant films. Am J Respir Cell Mol Biol 2004, 30:641–650.CrossRefPubMed Panda AK, Nag K, Harbottle RR, Rodriguez-Capote K, Veldhuizen RA, Petersen NO, Possmayer F: Effect of acute lung injury on structure and function of pulmonary surfactant films. Am J Respir Cell Mol Biol 2004, 30:641–650.CrossRefPubMed
7.
go back to reference Jobe AH: Phospholipid Metabolism and Turnover. In Fetal and Neonatal Physiology. Edited by: Polin RA and Fox WW. Philadelphia, W. B. Saunders Company; 1992. Jobe AH: Phospholipid Metabolism and Turnover. In Fetal and Neonatal Physiology. Edited by: Polin RA and Fox WW. Philadelphia, W. B. Saunders Company; 1992.
8.
go back to reference Malloy J, McCaig L, Veldhuizen RA, Yao LJ, Joseph M, Whitsett J, Lewis J: Alterations of endogenous surfactant system in septic adult rats. Am J Respir Crit Care Med 1997, 156:617–623.CrossRefPubMed Malloy J, McCaig L, Veldhuizen RA, Yao LJ, Joseph M, Whitsett J, Lewis J: Alterations of endogenous surfactant system in septic adult rats. Am J Respir Crit Care Med 1997, 156:617–623.CrossRefPubMed
9.
go back to reference Lewis JF, Ikegami M, Jobe A: Altered surfactant function and metabolism in rabbits with acute lung injury. J Appl Physiol 1990, 69:2303–2310.PubMed Lewis JF, Ikegami M, Jobe A: Altered surfactant function and metabolism in rabbits with acute lung injury. J Appl Physiol 1990, 69:2303–2310.PubMed
10.
go back to reference Gurel O, Ikegami M, Chroneos ZC, Jobe AH: Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1266–72.PubMed Gurel O, Ikegami M, Chroneos ZC, Jobe AH: Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1266–72.PubMed
11.
go back to reference Rider ED, Ikegami M, Jobe A: Intrapulmonary catabolism of surfactant-saturated phospatidylcholine in rabbits. J Appl Physiol 1990, 69:1856–1862.PubMed Rider ED, Ikegami M, Jobe A: Intrapulmonary catabolism of surfactant-saturated phospatidylcholine in rabbits. J Appl Physiol 1990, 69:1856–1862.PubMed
12.
go back to reference Atallah HL, Wu Y, Alaoui-El-Azer M, Thouron F, Koumanof K, Wolf C, Brochard L, Harf A, Delclaux C, Touqui L: Induction of type-IIA secretory phospholipase A2 in animal model of acute lung injury. Eur Respir J 2003, 21:1040–1045.CrossRef Atallah HL, Wu Y, Alaoui-El-Azer M, Thouron F, Koumanof K, Wolf C, Brochard L, Harf A, Delclaux C, Touqui L: Induction of type-IIA secretory phospholipase A2 in animal model of acute lung injury. Eur Respir J 2003, 21:1040–1045.CrossRef
13.
go back to reference Fisher AB, Dodia C: Lysosomal-type PLA2 and turnover of alveolar DPPC. Am J Physiol Lung Cell Mol Physiol 2001, 280:L748–54.PubMed Fisher AB, Dodia C: Lysosomal-type PLA2 and turnover of alveolar DPPC. Am J Physiol Lung Cell Mol Physiol 2001, 280:L748–54.PubMed
14.
go back to reference Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall R, Morris A, Spragg R: The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trials cohordination. Am Rev Respir Dis 1994, 149:818–824.CrossRef Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall R, Morris A, Spragg R: The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trials cohordination. Am Rev Respir Dis 1994, 149:818–824.CrossRef
15.
go back to reference Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911–917.CrossRefPubMed Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911–917.CrossRefPubMed
16.
go back to reference Mason J, Nellenbogen J, Clements JA: Isolation of desaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 1976, 17:281–284.PubMed Mason J, Nellenbogen J, Clements JA: Isolation of desaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 1976, 17:281–284.PubMed
17.
go back to reference Christie WW: The analysis of fatty acids. In Gas chromatography and lipids A practical guide. Edited by: Christie WW. Ayr, Scotland, The oil press; 1989:64–84. Christie WW: The analysis of fatty acids. In Gas chromatography and lipids A practical guide. Edited by: Christie WW. Ayr, Scotland, The oil press; 1989:64–84.
18.
go back to reference Torresin M, Zimmermann LJI, Cogo PE, Cavicchioli P, Badon T, Giordano G, Zacchello F, Sauer PJJ, Carnielli VP: Exogenous Surfactant Kinetics in Infant Respiratory Distress Syndrome: a Novel Method with Stable Isotopes. Am J Respir Crit Care Med 2000, 161:1584–1589.CrossRefPubMed Torresin M, Zimmermann LJI, Cogo PE, Cavicchioli P, Badon T, Giordano G, Zacchello F, Sauer PJJ, Carnielli VP: Exogenous Surfactant Kinetics in Infant Respiratory Distress Syndrome: a Novel Method with Stable Isotopes. Am J Respir Crit Care Med 2000, 161:1584–1589.CrossRefPubMed
19.
go back to reference Pinto RA, Wright JR, Lesikar D, Benson BJ, Clements JA: Uptake of pulmonary surfactant protein C into adult rat lung lamellar bodies. J Appl Physiol 1993, 74:1005–1011.PubMed Pinto RA, Wright JR, Lesikar D, Benson BJ, Clements JA: Uptake of pulmonary surfactant protein C into adult rat lung lamellar bodies. J Appl Physiol 1993, 74:1005–1011.PubMed
20.
go back to reference Hallman M, Epstein BL, Gluck L: Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage. J Clin Invest 1981, 68:742–751.CrossRefPubMedPubMedCentral Hallman M, Epstein BL, Gluck L: Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage. J Clin Invest 1981, 68:742–751.CrossRefPubMedPubMedCentral
21.
go back to reference Baritussio A, Pettenazzo A, Benevento M, Alberti A, Gamba P: Surfactant protein C is recycled from the alveoli to the lamellar bodies. Am J Physiol 1992, 263:L607-L611.PubMed Baritussio A, Pettenazzo A, Benevento M, Alberti A, Gamba P: Surfactant protein C is recycled from the alveoli to the lamellar bodies. Am J Physiol 1992, 263:L607-L611.PubMed
22.
go back to reference Cobelli C, Foster D, Toffolo G: . In Tracer Kinetics in Biomedical Research. New York, USA, Plenum Publisher; 2000. Cobelli C, Foster D, Toffolo G: . In Tracer Kinetics in Biomedical Research. New York, USA, Plenum Publisher; 2000.
23.
go back to reference DiStefano JJI: Complete parameter bounds and quasiidentifiability conditions for a class of unidentifiable linear system. Math Biosci 1983, 65:51–68.CrossRef DiStefano JJI: Complete parameter bounds and quasiidentifiability conditions for a class of unidentifiable linear system. Math Biosci 1983, 65:51–68.CrossRef
24.
go back to reference Barret PHR, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster D: SAAMII: simulation, analysis and modeling software for tracer and pharmacokinetics studies. Metabolism 1998, 47:484–492.CrossRef Barret PHR, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster D: SAAMII: simulation, analysis and modeling software for tracer and pharmacokinetics studies. Metabolism 1998, 47:484–492.CrossRef
25.
go back to reference Nakos G, Kitsiouli EI, Tsangaris I, Lekka ME: Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med 1998, 24:296–303.CrossRefPubMed Nakos G, Kitsiouli EI, Tsangaris I, Lekka ME: Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med 1998, 24:296–303.CrossRefPubMed
26.
go back to reference Baudouin SV: Exogenous surfactant replacement in ARDS-one day, someday, or never? New Engl J Med 2004, 351:853–855.CrossRefPubMed Baudouin SV: Exogenous surfactant replacement in ARDS-one day, someday, or never? New Engl J Med 2004, 351:853–855.CrossRefPubMed
27.
go back to reference Schmidt R, Meier U, Yabut-Perez M, Walmrath D, Grimminger F, Seeger W, Gunther A: Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med 2001, 163:95–100.CrossRefPubMed Schmidt R, Meier U, Yabut-Perez M, Walmrath D, Grimminger F, Seeger W, Gunther A: Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med 2001, 163:95–100.CrossRefPubMed
28.
go back to reference Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN: Aerosolized surfactants in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996, 334:1417–1421.CrossRefPubMed Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN: Aerosolized surfactants in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996, 334:1417–1421.CrossRefPubMed
29.
go back to reference Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, Moxley MA, Cai GZ, Hite RD, Smith RM, Hudson LD, Crim C, Newton P, Mitchell BR, Gold AJ: Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997, 155:1309–1315.CrossRefPubMed Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, Moxley MA, Cai GZ, Hite RD, Smith RM, Hudson LD, Crim C, Newton P, Mitchell BR, Gold AJ: Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997, 155:1309–1315.CrossRefPubMed
30.
go back to reference Spraag RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W: Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. New Engl J Med 2004, 351:884–892.CrossRef Spraag RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W: Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. New Engl J Med 2004, 351:884–892.CrossRef
31.
go back to reference Janssen DJ, Carnielli VP, Cogo PE, Seidner SR, Luijendijk IHI, Wattimena DJL, Jobe AH, Zimmermann LJI: Surfactant phosphatidylcholine half-life and pool size measurements in premature baboons developing BPD. Pediatr Res 2002, 52:724–729.CrossRefPubMed Janssen DJ, Carnielli VP, Cogo PE, Seidner SR, Luijendijk IHI, Wattimena DJL, Jobe AH, Zimmermann LJI: Surfactant phosphatidylcholine half-life and pool size measurements in premature baboons developing BPD. Pediatr Res 2002, 52:724–729.CrossRefPubMed
32.
go back to reference Janssen DJ, Tibboel D, Carnielli VP, van Emmen E, Luijendijk IHI, Wattimena JLD, Zimmermann LJI: Surfactant phosphatidylcholine pool size in human neonates with congenital diaphragmatic hernia requiring ECMO. J Pediatr 2003, 142:247–252.CrossRefPubMed Janssen DJ, Tibboel D, Carnielli VP, van Emmen E, Luijendijk IHI, Wattimena JLD, Zimmermann LJI: Surfactant phosphatidylcholine pool size in human neonates with congenital diaphragmatic hernia requiring ECMO. J Pediatr 2003, 142:247–252.CrossRefPubMed
33.
go back to reference Cogo PE, Carnielli VP, Bunt JEH, Badon T, Giordano G, Zacchello F, Sauer PJJ, Zimmermann LJI: Endogenous surfactant metabolism in critically ill infants measured with stable isotopes labeled fatty acids. Pediatr Res 1999, 45:242–246.CrossRefPubMed Cogo PE, Carnielli VP, Bunt JEH, Badon T, Giordano G, Zacchello F, Sauer PJJ, Zimmermann LJI: Endogenous surfactant metabolism in critically ill infants measured with stable isotopes labeled fatty acids. Pediatr Res 1999, 45:242–246.CrossRefPubMed
34.
go back to reference Cogo PE, Zimmermann LJ, Rosso F, Tormena F, Gamba P, Verlato G, Baritussio A, Carnielli VP: Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia. Am J Respir Crit Care Med 2002, 166:154–158.CrossRefPubMed Cogo PE, Zimmermann LJ, Rosso F, Tormena F, Gamba P, Verlato G, Baritussio A, Carnielli VP: Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia. Am J Respir Crit Care Med 2002, 166:154–158.CrossRefPubMed
35.
go back to reference Cogo PE, Zimmermann LJI, Pesavento R, Sacchetto E, Burighel A, Rosso F, Badon T, Verlato G, Carnielli VP: Surfactant Kinetics in Preterm Infants on mechanical ventilation who did and did not developed Bronchopulmonary Dysplasia (BPD). Crit Care Med 2003, 31:1532–1538.CrossRefPubMed Cogo PE, Zimmermann LJI, Pesavento R, Sacchetto E, Burighel A, Rosso F, Badon T, Verlato G, Carnielli VP: Surfactant Kinetics in Preterm Infants on mechanical ventilation who did and did not developed Bronchopulmonary Dysplasia (BPD). Crit Care Med 2003, 31:1532–1538.CrossRefPubMed
36.
go back to reference Cogo PE, Zimmermann LJI, Meneghini L, Mainini N, Bordignon L, Suma V, Buffo M, Carnielli VP: Pulmonary surfactant disaturated-phosphatidylcholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res 2003, 54:653–658.CrossRefPubMed Cogo PE, Zimmermann LJI, Meneghini L, Mainini N, Bordignon L, Suma V, Buffo M, Carnielli VP: Pulmonary surfactant disaturated-phosphatidylcholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res 2003, 54:653–658.CrossRefPubMed
37.
go back to reference Oyarzum MJ, Clements JA, Baritussio A: Ventilation enhances pulmonary alveolar clearance of radioactive dipalmitoyl phosphatidylcholine in liposomes. Am Rev Respir Dis 1980, 121:709–721. Oyarzum MJ, Clements JA, Baritussio A: Ventilation enhances pulmonary alveolar clearance of radioactive dipalmitoyl phosphatidylcholine in liposomes. Am Rev Respir Dis 1980, 121:709–721.
38.
go back to reference Davis JM, Russ GA, Metlay L, Dickerson B, Greenspan BS: Short term distribution kinetics of intratracheally administered exogenous lung surfactant. Pediatr Res 1992, 31:445–450.CrossRefPubMed Davis JM, Russ GA, Metlay L, Dickerson B, Greenspan BS: Short term distribution kinetics of intratracheally administered exogenous lung surfactant. Pediatr Res 1992, 31:445–450.CrossRefPubMed
39.
go back to reference Ueda T, Ikegami M, Rider ED, Jobe A: Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol 1994, 76:45–55.PubMed Ueda T, Ikegami M, Rider ED, Jobe A: Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol 1994, 76:45–55.PubMed
40.
go back to reference Rebello CM, Jobe AH, Eisele JW, Ikegami M: Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med 1996, 154:625–628.CrossRefPubMed Rebello CM, Jobe AH, Eisele JW, Ikegami M: Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med 1996, 154:625–628.CrossRefPubMed
41.
go back to reference DiStefano JJ, Malone TK, Jang M: Comprehensive kinetics of thyroxine (T4) distribution and metabolism in blood and tissue pools of the rat from only 6 blood samples: dominance of large, slowly exchainging tissue pool. Endocrinology 1982, 111:108–117.CrossRefPubMed DiStefano JJ, Malone TK, Jang M: Comprehensive kinetics of thyroxine (T4) distribution and metabolism in blood and tissue pools of the rat from only 6 blood samples: dominance of large, slowly exchainging tissue pool. Endocrinology 1982, 111:108–117.CrossRefPubMed
42.
go back to reference DiStefano JJ, Jang M, Malone TK, Broutman M: Comprehensive kinetics of triiodothyronine (T3) production distribution and metabolism in blood and tissue pools of the rat using optimised blood sampling protocol. Endocrinology 1982, 110:198–213.CrossRefPubMed DiStefano JJ, Jang M, Malone TK, Broutman M: Comprehensive kinetics of triiodothyronine (T3) production distribution and metabolism in blood and tissue pools of the rat using optimised blood sampling protocol. Endocrinology 1982, 110:198–213.CrossRefPubMed
43.
go back to reference Cobelli C, Toffolo G: Theoretical aspects and practical strategies for the identification of unidentifiable compartmental systems. In Identifiability of Parametric Models. Edited by: Walter E. Oxford, Pergamon Press; 1987:85–91. Cobelli C, Toffolo G: Theoretical aspects and practical strategies for the identification of unidentifiable compartmental systems. In Identifiability of Parametric Models. Edited by: Walter E. Oxford, Pergamon Press; 1987:85–91.
44.
go back to reference Martini WZ, Chinkes DL, Barrow RE, Murphey ED, Wolfe RR: Lung surfactant kinetics in conscious pigs. Am J Physiol 1999, 277:E187–95.PubMed Martini WZ, Chinkes DL, Barrow RE, Murphey ED, Wolfe RR: Lung surfactant kinetics in conscious pigs. Am J Physiol 1999, 277:E187–95.PubMed
45.
go back to reference Young SL, Kremers SA, Apple JS, Crapo JD, Brumley GW: Rat lung surfactant kinetics biochemical and morphometric correlation. J Appl Physiol 1981, 51:248–253.PubMed Young SL, Kremers SA, Apple JS, Crapo JD, Brumley GW: Rat lung surfactant kinetics biochemical and morphometric correlation. J Appl Physiol 1981, 51:248–253.PubMed
46.
go back to reference Fisher AB, Dodia C, Feinstein SI, Ho YS: Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2. J Lipid Res 2005,46(6):1248–56.CrossRefPubMed Fisher AB, Dodia C, Feinstein SI, Ho YS: Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2. J Lipid Res 2005,46(6):1248–56.CrossRefPubMed
Metadata
Title
Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model
Authors
Paola E Cogo
Gianna Maria Toffolo
Carlo Ori
Andrea Vianello
Marco Chierici
Antonina Gucciardi
Claudio Cobelli
Aldo Baritussio
Virgilio P Carnielli
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2007
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-8-13

Other articles of this Issue 1/2007

Respiratory Research 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.